These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 21909397)

  • 1. Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
    Wilson EB; El-Jawhari JJ; Neilson AL; Hall GD; Melcher AA; Meade JL; Cook GP
    PLoS One; 2011; 6(9):e22842. PubMed ID: 21909397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression.
    Fujii R; Jochems C; Tritsch SR; Wong HC; Schlom J; Hodge JW
    Cancer Immunol Immunother; 2018 Apr; 67(4):675-689. PubMed ID: 29392336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β signalling limits effector function capacity of NK cell anti-tumour immunity in human bladder cancer.
    Wong JKM; McCulloch TR; Alim L; Omer N; Mehdi AM; Tuong ZK; Bonfim-Melo A; Chung E; Nicol A; Simpson F; Rhee H; Rossi GR; Souza-Fonseca-Guimaraes F
    EBioMedicine; 2024 Jun; 104():105176. PubMed ID: 38810560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the effects of inhibitory cytokines on human natural killer cells and the mechanistic features of transforming growth factor-beta.
    Lee HM; Kim KS; Kim J
    Cell Immunol; 2014 Jul; 290(1):52-61. PubMed ID: 24879062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β regulated leukemia cell susceptibility against NK targeting through the down-regulation of the CD48 expression.
    Huang CH; Liao YJ; Chiou TJ; Huang HT; Lin YH; Twu YC
    Immunobiology; 2019 Sep; 224(5):649-658. PubMed ID: 31421859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma.
    Close HJ; Stead LF; Nsengimana J; Reilly KA; Droop A; Wurdak H; Mathew RK; Corns R; Newton-Bishop J; Melcher AA; Short SC; Cook GP; Wilson EB
    Clin Exp Immunol; 2020 Apr; 200(1):33-44. PubMed ID: 31784984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway.
    Viel S; Marçais A; Guimaraes FS; Loftus R; Rabilloud J; Grau M; Degouve S; Djebali S; Sanlaville A; Charrier E; Bienvenu J; Marie JC; Caux C; Marvel J; Town L; Huntington ND; Bartholin L; Finlay D; Smyth MJ; Walzer T
    Sci Signal; 2016 Feb; 9(415):ra19. PubMed ID: 26884601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of c-Myb in the regulation of natural killer cell activity.
    Shin HW; Lee YJ; Kim J
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2807-2813. PubMed ID: 30103947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocytes and the 38kDa-antigen of mycobacterium tuberculosis modulate natural killer cell activity and their cytolysis directed against ovarian cancer cell lines.
    Gottschalk N; Lang S; Kimmig R; Singh M; Brandau S
    BMC Cancer; 2012 Oct; 12():451. PubMed ID: 23036052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
    Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
    Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4.
    Salvucci O; Mami-Chouaib F; Moreau JL; Thèze J; Chehimi J; Chouaib S
    Eur J Immunol; 1996 Nov; 26(11):2736-41. PubMed ID: 8921963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artesunate down-regulates immunosuppression from colorectal cancer Colon26 and RKO cells in vitro by decreasing transforming growth factor β1 and interleukin-10.
    Cui C; Feng H; Shi X; Wang Y; Feng Z; Liu J; Han Z; Fu J; Fu Z; Tong H
    Int Immunopharmacol; 2015 Jul; 27(1):110-21. PubMed ID: 25978851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of Natural Killer Cell-Mediated Tumor Immunity by an IL15/TGFβ-Neutralizing Fusion Protein.
    Ng S; Deng J; Chinnadurai R; Yuan S; Pennati A; Galipeau J
    Cancer Res; 2016 Oct; 76(19):5683-5695. PubMed ID: 27488533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined immunogene therapy of IL-6 and IL-15 enhances anti-tumor activity through augmented NK cytotoxicity.
    Lin CY; Chuang TF; Liao KW; Huang YJ; Pai CC; Chu RM
    Cancer Lett; 2008 Dec; 272(2):285-95. PubMed ID: 18760876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β.
    Sarhan D; Palma M; Mao Y; Adamson L; Kiessling R; Mellstedt H; Österborg A; Lundqvist A
    Eur J Immunol; 2015 Jun; 45(6):1783-93. PubMed ID: 25773885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of NK cell functions by TGF-beta 1.
    Bellone G; Aste-Amezaga M; Trinchieri G; Rodeck U
    J Immunol; 1995 Aug; 155(3):1066-73. PubMed ID: 7636180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    Otegbeye F; Ojo E; Moreton S; Mackowski N; Lee DA; de Lima M; Wald DN
    PLoS One; 2018; 13(1):e0191358. PubMed ID: 29342200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asiaticoside modulates human NK cell functional fate by mediating metabolic flexibility in the tumor microenvironment.
    Guo Y; Xu J; Jia Y; Tian Y; Zhang Y; Zhang J; Wang Y; Chen L
    Phytomedicine; 2024 Oct; 133():155921. PubMed ID: 39121533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia.
    Rouce RH; Shaim H; Sekine T; Weber G; Ballard B; Ku S; Barese C; Murali V; Wu MF; Liu H; Shpall EJ; Bollard CM; Rabin KR; Rezvani K
    Leukemia; 2016 Apr; 30(4):800-11. PubMed ID: 26621337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unique phenotype of human uterine NK cells and their regulation by endogenous TGF-beta.
    Eriksson M; Meadows SK; Wira CR; Sentman CL
    J Leukoc Biol; 2004 Sep; 76(3):667-75. PubMed ID: 15178706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.